Cancer Committee

The Cancer Committee is the designated multidisciplinary body for the administrative oversight, development, and review of cancer care services at Stony Brook Medicine. The Committee communicates directly with the Hospital’s medical board, and its activities and recommendations directly impact programs. Members include physician representatives from the medical, surgical, diagnostic, and clinical areas along with representatives from supporting services involved with the care of patients with cancer. Its composition must include board-certified physicians from surgery, medical oncology, radiation oncology, diagnostic radiology, and pathology, along with a cancer liaison physician, clinical research manager, pain control/palliative care specialist, and representatives from Hospital administration, nursing, social services, cancer registry, and quality assurance. In 2010, a permanent member representing the American Cancer Society joined, and representation from the medical oncology community physician continued. Committees and work groups meet on Cancer Leadership, Cancer Quality Service, Tumor Board and Cancer Conferences, and Community Outreach and External Relations.

The Cancer Committee is charged with providing leadership to plan, initiate, stimulate and assess the institution’s cancer-related activities, in accordance with the Commission on Cancer requirements for cancer program accreditation. Stony Brook Cancer Center is accredited at the level of Academic Comprehensive Cancer Program and has maintained continuous program accreditation since 1986.

2024 Cancer Committee Membership